These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Meibomian gland dysfunction: hyperkeratinization or atrophy? Jester JV; Parfitt GJ; Brown DJ BMC Ophthalmol; 2015 Dec; 15 Suppl 1(Suppl 1):156. PubMed ID: 26817690 [TBL] [Abstract][Full Text] [Related]
8. Dry Eye Disease Associated with Meibomian Gland Dysfunction: Focus on Tear Film Characteristics and the Therapeutic Landscape. Sheppard JD; Nichols KK Ophthalmol Ther; 2023 Jun; 12(3):1397-1418. PubMed ID: 36856980 [TBL] [Abstract][Full Text] [Related]
9. Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: Proceedings of the OCEAN group meeting. Geerling G; Baudouin C; Aragona P; Rolando M; Boboridis KG; Benítez-Del-Castillo JM; Akova YA; Merayo-Lloves J; Labetoulle M; Steinhoff M; Messmer EM Ocul Surf; 2017 Apr; 15(2):179-192. PubMed ID: 28132878 [TBL] [Abstract][Full Text] [Related]
10. Correlation Study Between Abnormal Morphology of Meibomian Glands and Meibum in Patients With Dry Eye Disease Under Zheng Q; Xue Y; Zhong X; Li G; Shi W; Wang T Front Med (Lausanne); 2021; 8():793338. PubMed ID: 35096880 [No Abstract] [Full Text] [Related]
11. Pathophysiology of Meibomian Glands - An Overview. Dietrich J; Garreis F; Paulsen F Ocul Immunol Inflamm; 2021 May; 29(4):803-810. PubMed ID: 33945389 [No Abstract] [Full Text] [Related]
12. Evaporative dry eye disease due to meibomian gland dysfunction: Preferred practice pattern guidelines for diagnosis and treatment. Narang P; Donthineni PR; D'Souza S; Basu S Indian J Ophthalmol; 2023 Apr; 71(4):1348-1356. PubMed ID: 37026266 [TBL] [Abstract][Full Text] [Related]
13. Meibocyte differentiation and renewal: Insights into novel mechanisms of meibomian gland dysfunction (MGD). Hwang HS; Parfitt GJ; Brown DJ; Jester JV Exp Eye Res; 2017 Oct; 163():37-45. PubMed ID: 28219733 [TBL] [Abstract][Full Text] [Related]
14. Functional and Morphological Evaluation of Meibomian Glands in the Assessment of Meibomian Gland Dysfunction Subtype and Severity. Xiao J; Adil MY; Chen X; Utheim ØA; Ræder S; Tønseth KA; Lagali NS; Dartt DA; Utheim TP Am J Ophthalmol; 2020 Jan; 209():160-167. PubMed ID: 31526799 [TBL] [Abstract][Full Text] [Related]
15. Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction. Cote S; Zhang AC; Ahmadzai V; Maleken A; Li C; Oppedisano J; Nair K; Busija L; Downie LE Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013559. PubMed ID: 32182637 [TBL] [Abstract][Full Text] [Related]
16. The contribution of meibomian disease to dry eye. Bron AJ; Tiffany JM Ocul Surf; 2004 Apr; 2(2):149-65. PubMed ID: 17216085 [TBL] [Abstract][Full Text] [Related]
17. Human meibum and tear film derived cholesteryl and wax esters in meibomian gland dysfunction and tear film structure. Khanal S; Bai Y; Ngo W; Nichols KK; Wilson L; Barnes S; Nichols JJ Ocul Surf; 2022 Jan; 23():12-23. PubMed ID: 34774809 [TBL] [Abstract][Full Text] [Related]
19. Lipid layer thickness decrease due to meibomian gland dysfunction leads to tear film instability and reflex tear secretion. Kim WJ; Ahn YJ; Kim MH; Kim HS; Kim MS; Kim EC Ann Med; 2022 Dec; 54(1):893-899. PubMed ID: 35379048 [TBL] [Abstract][Full Text] [Related]